Preventing cardiac damage in patients with COVID-19

Nat Rev Cardiol. 2021 Jun;18(6):387. doi: 10.1038/s41569-021-00550-3.


A cardiac organoid approach combined with phosphoproteomics and single nuclei RNA-sequencing identifies bromodomain and extraterminal family inhibitors as promising candidates to prevent COVID-19 mediated cardiac damage.

Publication types

  • Comment

MeSH terms

  • COVID-19*
  • Heart
  • Heart Diseases* / prevention & control
  • Humans
  • Inflammation
  • SARS-CoV-2